Apixaban Market: by dosage form (capsule and tablet), and end-users (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies and Others)– Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Apixaban Market: by dosage form (capsule and tablet), and end-users (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies and Others)– Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

07-Nov-2019 | Number of pages: 130 | Report Code: ZMR-4983 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the Apixaban market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Apixaban market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Apixaban market on a global level. In order to give the users of this report a comprehensive view on the Apixaban market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein dosage form, end-users and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

Apixaban is a Food and Drug Administration (FDA) licensed anticoagulant used in the treatment of thromboembolic venous events (blood clot) within a vein. Venous thromboembolic events (VTEs) occurring without any prior symptoms or warning signs and may go undiagnosed or unrecognized by a health care professional. Symptoms that occur may be associated with either pulmonary embolism (PE) or deep vein thrombosis (DVT) such as calf pain, ankle and foot swelling, redness or visible spots of discolouration, rapid respiration, chest pain, or others. Apixaban is sold under Eliquis's trade name. Factor Xa is a serine protease-like trypsin that plays a important role in the cascade of blood coagulation. Apixaban mechanism works on Xa factor inhibiting which indirectly decreases thrombin-stimulated clot formation. Apixaban is recommended in patients with non-valvular atrial fibrillation to reduce the risk of stroke or systemic embolism. Eliquis' recommended dose is 5 mg twice daily orally. Apixaban is available on the market in the form of pills or tablets.

The study provides a decisive view on the Apixaban market by segmenting the market based on dosage form, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on dosage form, the market is segmented into capsule and tablet. Based on end-users, the apixaban market is segmented into hospitals, clinics, retail pharmacies, online pharmacies and others.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries such as US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. In terms of revenue generated by the drug's high price, North America holds the dominant position in treating venous thromboembolic events. For example, according to a study published in the 2010 American Journal of Preventive Medicine, venous thromboembolism (VTE) affects between 300,000-600,000 people annually in the U.S., causing significant mortality. Additionally, the disorder of venous thromboembolism (VTE) may occur in all ethnicities, all age groups, and both sexes.

Increasing prevalence of conditions related to venous thromboembolism is expected to support apixaban market growth. For example, according to facts from the International Society on Thrombosis and Haemostasis 2014, around 10 million cases of venous thromboembolism occur in low, middle and high-income countries annually. In 2014, for example, the U.S. Eliquis was approved by the Food and Drug Administration for the treatment of deep vein thrombosis (DVT) prophylaxis and pulmonary embolism (PE) and also for the reduction of the risk of recurrent PE and DVT after initial treatment. In addition, government and private organizations are investing heavily in research and development in health care, and this is also likely to boost the growth of the Apixaban market. However, it is expected that adverse effects of apixaban such as increased risk of thrombotic events following premature discontinuation and bleeding will hinder its adoption. This in turn is projected to have an adverse impact on market growth.

Key players within global Apixaban market include Abbott, Alere, Bristol-Myers Squibb, C. H. Boehringer Sohn, CoaguSense, Pfizer, Portola Pharmaceuticals, Roche, Siemens amongst others.

The report segments global Apixaban market as follows:

Global Apixaban Market: Dosage Form Segment Analysis

  • Capsule
  • Tablet

Global Apixaban Market: End-user Segment Analysis

  • Hospitals
  • Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Global Apixaban Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Healthcare Fraud Analytics Market – By Solution Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics), By Delivery Model (On-premise and On-Demand), By Component (Services and Software), By Application (Insurance Claims Review, Pharmacy Billing Misuse, Payment Integrity, and Others), By End-User (Private Insurance Payers, Public & Government Agencies, Third-Party Service Providers, and Employers), and By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Feb-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5291 | Report Format:

This report analyzes and estimates the Healthcare Fraud Analytics market at global, regional, and country level. The research study provides historic data from 2015 to 2019 along with forecast from 2020 to 2025 based on value (USD Billion). The report offers detailed insights of the Healthcare Fra...Read More

Aquaculture Healthcare Market – By Product (Vaccines, Drug, and Medicated Feed Additives), By Infection (Fungal Infections, Viral Infections, Bacterial Infections, and Parasitic Infections), By Route Of Administration (Injectable, Oral, and Topical), By Species (Crustaceans and Fishes), By Distribution Channel (Retail/aqua stores, Online Stores, Distributors, and Others), and By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2025

Feb-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5265 | Report Format:

This report analyzes and estimates the aquaculture healthcare market at global, regional, and country level. The research study provides historic data from 2016 to 2019 along with the forecast from 2020 to 2025 based on revenue (USD Million). The report offers detailed insights of the aquaculture ...Read More

Fertility Test Market – By Product (Ovulation Predictor Kits (OPK) and Fertility Monitors (Urine & Saliva-based)), By Mode of Purchase (OTC and Prescription), By Application (Female Fertility Testing and Male Fertility Testing), By End-User (Homecare Settings, Fertility Clinics, Hospital, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2026

Feb-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5256 | Report Format:

This report analyzes and estimates the Fertility Test market at global, regional, and country level. The research study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The report offers detailed insights of the Fertility Test market dr...Read More

Cardiac Mapping Market – By Product (Contact Cardiac mapping systems and Non-contact Cardiac mapping systems), By Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry tachycardia (AVNRT), and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2026

Feb-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5254 | Report Format:

This report analyzes and estimates the Cardiac Mapping market at global, regional, and country level. The research study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Billion). The report offers detailed insights of the Cardiac Mapping market ...Read More

Small Molecule Targeted Cancer Therapy Market by Type (Small Molecule Drug Conjugates, Small Molecules and Monoclonal Antibodies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Feb-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5253 | Report Format:

The report covers forecast and analysis for the small molecule targeted cancer therapy market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the small mol...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.